Explore by placeOpen map
01India 02State / UT 03District 04City / Block 05Village / Ward 06Street report
18 national pillarsAll problems
01School Theek Karo 02Food & Agriculture 03Water & Sanitation 04Health & Nutrition 05Jobs, MSMEs & Economy 06Governance, Justice & Safety 07Energy, Environment & Climate 08Cities, Housing & Infrastructure 09Transport & Logistics 10Industry & Manufacturing 11Digital, Science & Innovation 12Society, Culture & Quality of Life 13Women Safety, Health & Empowerment 14Defence, Security & Resilience 15Population & Demography 16Finance, Capital & Public Value 17Energy Security & Transition 18Global India & Cooperation
Research and actionUniversity network
01Problems 02Evidence & Research 03Solutions 04Initiatives & Pilots 05Progress 06Ideas & Evidence 07Write an Article 08Global Research Network 09Best in India 10Contribute 11People & Members
HEALTH SYSTEM 30 OF 45

Genomics & Precision Health

Advance rare-disease and treatment research with strong rights safeguards.

System intelligence—not personal medical diagnosis or treatment advice.
01 · PLACE & PROBLEM

Describe the patient or population failure precisely.

Genomic data is highly sensitive, family-linked and vulnerable to over-interpretation, discrimination and insecure reuse.

Advance rare-disease and treatment research with strong rights safeguards. requires evidence of actual access, readiness, quality, safety, affordability and continuity—not only a scheme, facility or installed asset.

Required context

Record state, district, city/block, village/ward or facility; date and time; population or patient group without unnecessary identity; service stage; observed harm or delay; source/method; and uncertainty. For emergencies and personal treatment, contact qualified local services rather than waiting for platform review.

02 · ROOT-CAUSE DIRECTION

Investigate the service chain, not only the visible symptom.

01

Need & access

Who needs care, who reaches it and who is excluded? Test records, direct observation, staff and patient experience, and credible alternatives before calling it a verified cause.

02

Capacity & capability

Are the correct people, skills, rooms, equipment and supplies functional? Test records, direct observation, staff and patient experience, and credible alternatives before calling it a verified cause.

03

Flow & coordination

Where do queues, referrals, reports and handoffs fail? Test records, direct observation, staff and patient experience, and credible alternatives before calling it a verified cause.

04

Quality & safety

Are clinical, infection, medication, privacy and dignity standards met? Test records, direct observation, staff and patient experience, and credible alternatives before calling it a verified cause.

05

Finance & governance

Who owns, pays, operates, maintains, monitors and corrects failure? Test records, direct observation, staff and patient experience, and credible alternatives before calling it a verified cause.

06

Context & equity

How do geography, gender, disability, income, language and season change the pathway? Test records, direct observation, staff and patient experience, and credible alternatives before calling it a verified cause.

03 · COMPLETE SYSTEM

Every component needs an accountable operating definition.

01

Genomic research

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

02

Rare diseases

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

03

Pharmacogenomics

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

04

Personalised treatment

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

05

Risk research

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

06

Genetic counselling

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

07

Privacy, consent and ethics

Define eligibility, service standard, responsible team, required inputs, handoff, safety rule, data record, escalation and follow-up.

04 · INDIA-FIT SOLUTION

Repair the weakest handoff while protecting the whole pathway.

01

Verify baseline

Measure the actual local failure in genomics & precision health, including distribution and missing evidence.

02

Protect immediately

Contain urgent patient-safety, infection, supply, access or continuity risks before longer reform.

03

Redesign service

Join people, workflow, infrastructure, supplies, digital support and accountability around the user journey.

04

Pilot safely

Pilot a tightly governed clinical use with counselling, consent, validation, access control and long-term oversight.

05

Independent review

Compare benefit, harm, equity, cost, workforce burden and maintainability before expansion.

Decision checksClinical safetyAccessConsentPrivacyEquityWorkforceAffordabilityMaintenanceEvidence
05 · ROADMAP

Protect now, pilot carefully and build durable capability.

0–90 DAYS

Diagnose & protect

Verify the pathway, immediate risk, accountable owner, minimum safe standard and urgent correction.

3–18 MONTHS

Pilot & measure

Pilot a tightly governed clinical use with counselling, consent, validation, access control and long-term oversight.

1–5+ YEARS

Institutionalise

Fund workforce, operations, maintenance, interoperability, supervision, public correction, independent evaluation and continuous learning.

06 · MEASURED RESULTS

Track health benefit, safety, equity and durability—not activity alone.

KPI 01Clinical utilityDefinition · baseline · target · actual · source · period · subgroup · uncertainty
KPI 02Consent comprehensionDefinition · baseline · target · actual · source · period · subgroup · uncertainty
KPI 03Equitable accessDefinition · baseline · target · actual · source · period · subgroup · uncertainty
KPI 04Data access auditDefinition · baseline · target · actual · source · period · subgroup · uncertainty
KPI 05Incidental-finding managementDefinition · baseline · target · actual · source · period · subgroup · uncertainty

Result status: Planned, baseline pending, active measurement, insufficient evidence, improved, mixed, no improvement or harmful. Never label a programme successful from spending, training, installation or coverage alone.

07 · RISKS & SAFEGUARDS

Improvement must not create avoidable clinical or social harm.

  • Clinical riskUnsafe standardisation, delay, false reassurance or inappropriate escalation.
  • Equity riskRemote, poor, disabled, female, older or language-minority users excluded.
  • Data riskConsent failure, exposure, cyber harm, misidentification or bad-quality records.
  • Workforce riskAutomation or targets increase unsafe workload and conceal skill gaps.
  • Governance riskResponsibility, funding, maintenance or remedy remains unclear.